180 related articles for article (PubMed ID: 9803426)
21. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
22. Increased sensitivity to alprazolam in females with a paternal history of alcoholism.
Evans SM; Levin FR; Fischman MW
Psychopharmacology (Berl); 2000 Jun; 150(2):150-62. PubMed ID: 10907668
[TBL] [Abstract][Full Text] [Related]
23. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
Chan AF; Mortola JF; Wood SH; Yen SS
Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453
[TBL] [Abstract][Full Text] [Related]
24. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
Steinberg S; Annable L; Young SN; Liyanage N
Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
26. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
Lin IM; Tsai YC; Peper E; Yen CF
J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
[TBL] [Abstract][Full Text] [Related]
27. Chromium supplementation for menstrual cycle-related mood symptoms.
Brownley KA; Girdler SS; Stout AL; McLeod MN
J Diet Suppl; 2013 Dec; 10(4):345-56. PubMed ID: 24237190
[TBL] [Abstract][Full Text] [Related]
28. Daytime sleepiness, psychomotor performance, waking EEG spectra and evoked potentials in women with severe premenstrual syndrome.
Baker FC; Colrain IM
J Sleep Res; 2010 Mar; 19(1 Pt 2):214-27. PubMed ID: 19840240
[TBL] [Abstract][Full Text] [Related]
29. Alprazolam and premenstrual syndrome.
Freinhar JP
J Clin Psychiatry; 1984 Dec; 45(12):526. PubMed ID: 6150031
[No Abstract] [Full Text] [Related]
30. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
Evans SM; Troisi JR; Griffiths RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
[TBL] [Abstract][Full Text] [Related]
31. Alprazolam in clinically anxious patients with depressed mood.
Aden GC
J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
[TBL] [Abstract][Full Text] [Related]
32. Fluoxetine in the treatment of premenstrual syndrome.
Stone AB; Pearlstein TB; Brown WA
Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
[TBL] [Abstract][Full Text] [Related]
33. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.
Gonda X; Telek T; Juhász G; Lazary J; Vargha A; Bagdy G
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1782-8. PubMed ID: 18721843
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.
Segebladh B; Borgström A; Odlind V; Bixo M; Sundström-Poromaa I
Contraception; 2009 Jan; 79(1):50-5. PubMed ID: 19041441
[TBL] [Abstract][Full Text] [Related]
35. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
[TBL] [Abstract][Full Text] [Related]
36. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
37. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Rickels K; Freeman EW
J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
[TBL] [Abstract][Full Text] [Related]
38. Response to flumazenil in women with premenstrual dysphoric disorder.
Le Mellédo JM; Van Driel M; Coupland NJ; Lott P; Jhangri GS
Am J Psychiatry; 2000 May; 157(5):821-3. PubMed ID: 10784479
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
Busto U; Kaplan HL; Zawertailo L; Sellers EM
Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
[TBL] [Abstract][Full Text] [Related]
40. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.
Leufkens TR; Vermeeren A; Smink BE; van Ruitenbeek P; Ramaekers JG
Psychopharmacology (Berl); 2007 May; 191(4):951-9. PubMed ID: 17219217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
